BCPC logo

Balchem Stock Price

Symbol: NasdaqGS:BCPCMarket Cap: US$5.1bCategory: Materials

BCPC Share Price Performance

US$160.00
-2.85 (-1.75%)
20.1% undervalued intrinsic discount
US$200.33
Fair Value
US$160.00
-2.85 (-1.75%)
20.1% undervalued intrinsic discount
US$200.33
Fair Value
Price US$160.00
AnalystConsensusTarget US$200.33

BCPC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$200.33 20.1% undervalued intrinsic discount

New York Facility And European Policies Will Reshape Nutrition Sectors

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent BCPC News & Updates

No updates

Balchem Corporation Key Details

US$985.9m

Revenue

US$633.0m

Cost of Revenue

US$353.0m

Gross Profit

US$210.2m

Other Expenses

US$142.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.40
Gross Margin
35.80%
Net Profit Margin
14.48%
Debt/Equity Ratio
15.0%

Balchem Corporation Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About BCPC

Founded
1967
Employees
1364
CEO
Theodore Harris
WebsiteView website
www.balchem.com

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

U.S. Market Performance

  • 7 Days: -0.2%
  • 3 Months: 12.2%
  • 1 Year: 22.4%
  • Year to Date: 7.7%
The Communication Services sector gained 3.4% while the market remained flat over the last week. As for the longer term, the market has risen 22% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading